“…This NLS mediates an interaction with a nuclear import factor transportin 1 (TNPO1), enabling the transport of FUS through the nuclear membrane (Guttinger et al, 2004;Lee et al, 2006;Dormann et al, 2010). The majority of ALS-associated FUS mutations fall within the NLS, which impairs interaction with TNPO1 and nuclear import (Bosco et al, 2010;Dormann et al, 2010;Gal et al, 2011;Niu et al, 2012;Vance et al, 2013). Consequently ALS cases with FUS mutations have FUS immunoreactive cytoplasmic inclusions in neuronal and glial cells (Kwiatkowski et al, 2009;Vance et al, 2009;Blair et al, 2010;Rademakers et al, 2010;Mackenzie et al, 2011).…”